The manipulation of DNA is an essential task carried out in biotechnological research to precisely edit a given sequence, create artificial genomes, express recombinant proteins,
Site-directed mutagenesis is a powerful technique that allows scientists to induce changes in genes and study protein structure and function across a diverse range of
Catalyzing the future of biotech, this article delves into the transformative power of the DBTL cycle in R&D. Explore how software automation is reshaping the landscape of synthetic biology, enhancing efficiency, precision, and innovation.
Explore the strategic choices in biotechnology IP management: balancing on-premises control with cloud scalability. This article examines how hosting decisions influence regulatory compliance, data security, and research efficiency in the biotech sector.
In the world of biotech product development, AI’s impact is undeniable. It leads to more accurate diagnostics, faster treatments, and adaptive vaccines, as demonstrated during the COVID-19 pandemic.
Dr. Eduardo Abeliuk is a U.S. based entrepreneur and technologist with over twenty years of experience driving technology development and innovation at various high-tech companies in the US. He is currently the Chairman and CEO at TeselaGen Biotech., a Silicon Valley based company that works at the interface between Biotechnology, Artificial Intelligence and Enterprise Software.
Biotechnology has enormous potential to solve some of the world’s most pressing challenges in health, food security, and the environment. Yet conventional methods for developing biotechnology products rely on trial-and-error based processes, which are slow and laborious. Through biological design automation, innovative and successful products can be developed at unprecedented speed.
The artificial intelligence revolution kicked into high gear seemingly overnight. Generative AI platforms like ChatGPT and Google Bard have dominated headlines for months as we explore the possibilities for this powerful new technology, which has potentially significant implications for nearly every industry on the planet.
Gene therapy is a rapidly evolving research field that aims to treat or cure genetic disorders by replacing, removing, or adding genetic material (i.e., DNA or RNA) into cells. One of the key tools used in gene therapy is viral vectors, which are engineered viruses that can deliver genetic material to cells.
Plasmids are a crucial tool for molecular cloning in genetic engineering. They are small, circular, double-stranded DNA molecules that can replicate independently within bacterial cells. Plasmids can be modified with a variety of genetic elements, making them versatile vehicles for gene expression, protein production, and more. In this article, we will discuss five popular plasmids that are commonly used in molecular cloning.